ELABELA plasma concentrations are increased in women with late-onset preeclampsia

Bogdan Panaitescu, Roberto Romero, Nardhy Gomez-Lopez, Percy Pacora, Offer Erez, Felipe Vadillo-Ortega, Lami Yeo, Sonia S. Hassan, Chaur Dong Hsu

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Objective: ELABELA is a newly discovered peptide hormone that appears to be implicated in the mechanisms leading to preeclampsia, independently of angiogenic factors. The aim of the current study was to investigate whether women with early- or late-onset preeclampsia have altered ELABELA plasma concentrations compared to gestational-age-matched normal pregnant women. Methods: This retrospective cross-sectional study focused on the maternal plasma samples collected from 232 women with a singleton pregnancy who were allocated into the following groups: (1) early-onset preeclampsia (<34 weeks of gestation, N = 56); (2) late-onset preeclampsia (≥34 weeks of gestation, N = 57); and (3) gestational-age-matched controls with a normal pregnancy [(<34 weeks of gestation, N = 59); (≥34 weeks of gestation, N = 60)]. ELABELA plasma concentrations were determined using a validated enzyme immunoassay. Results: (1) ELABELA plasma concentrations are higher in patients with late-onset preeclampsia compared with those from gestational-age-matched controls with a normal pregnancy [median: 7.99 ng/mL (IQR, 5.3–13.95 ng/mL) versus median: 4.17 ng/mL (IQR, 3–11.19 ng/mL), p =.001]; (2) ELABELA plasma concentrations in patients with early-onset preeclampsia do not differ from those of normal pregnant women [median: 6.09 ng/mL (IQR, 2.8–10.66 ng/mL) versus median: 4.02 ng/mL (IQR, 3.26–7.49), p =.32]; and (3) ELABELA plasma concentrations are higher in patients with late-onset preeclampsia compared to those with early-onset preeclampsia [median: 7.99 ng/mL (IQR, 5.3–13.95 ng/mL) versus median: 6.09 ng/mL (IQR, 2.8–10.66 ng/mL), p =.01]. Conclusion: ELABELA plasma concentrations are higher in patients with late-onset preeclampsia than in those with a normal pregnancy. However, women with early-onset preeclampsia have similar ELABELA plasma concentrations to those with a normal pregnancy. These findings provide insight into the ELABELA axis during the human syndrome of preeclampsia. In addition, these data support the concept that different pathophysiologic mechanisms are implicated in early- and late-onset preeclampsia.

Original languageEnglish (US)
Pages (from-to)5-15
Number of pages11
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume33
Issue number1
DOIs
StatePublished - Jan 2 2020
Externally publishedYes

Keywords

  • Apela
  • maternal vascular malperfusion
  • maternal vascular underperfusion
  • placenta
  • pregnancy
  • preterm delivery

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'ELABELA plasma concentrations are increased in women with late-onset preeclampsia'. Together they form a unique fingerprint.

Cite this